Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Rosiglitazone 98.0+%, TCI America™
CAS: 122320-73-4 Molecular Formula: C18H19N3O3S Molecular Weight (g/mol): 357.43 MDL Number: MFCD00871760 InChI Key: YASAKCUCGLMORW-UHFFFAOYNA-N PubChem CID: 77999 ChEBI: CHEBI:50122 IUPAC Name: 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione SMILES: CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
| PubChem CID | 77999 |
|---|---|
| CAS | 122320-73-4 |
| Molecular Weight (g/mol) | 357.43 |
| ChEBI | CHEBI:50122 |
| MDL Number | MFCD00871760 |
| SMILES | CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1 |
| IUPAC Name | 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione |
| InChI Key | YASAKCUCGLMORW-UHFFFAOYNA-N |
| Molecular Formula | C18H19N3O3S |
Rosuvastatin Calcium 95.0+%, TCI America™
CAS: 147098-20-2 Molecular Formula: C44H60CaF2N6O12S2 Molecular Weight (g/mol): 1007.189 MDL Number: MFCD04112702 InChI Key: LQFSLFAVBQEFBH-LSMDDVBQSA-N PubChem CID: 131673834 IUPAC Name: calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;molecular hydrogen SMILES: [HH].[HH].CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca]
| PubChem CID | 131673834 |
|---|---|
| CAS | 147098-20-2 |
| Molecular Weight (g/mol) | 1007.189 |
| MDL Number | MFCD04112702 |
| SMILES | [HH].[HH].CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca] |
| IUPAC Name | calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid;molecular hydrogen |
| InChI Key | LQFSLFAVBQEFBH-LSMDDVBQSA-N |
| Molecular Formula | C44H60CaF2N6O12S2 |
Repaglinide 98.0+%, TCI America™
CAS: 135062-02-1 Molecular Formula: C27H36N2O4 Molecular Weight (g/mol): 452.60 MDL Number: MFCD00906179 InChI Key: FAEKWTJYAYMJKF-QHCPKHFHSA-N Synonym: (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic Acid PubChem CID: 65981 ChEBI: CHEBI:8805 IUPAC Name: 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid SMILES: CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O
| PubChem CID | 65981 |
|---|---|
| CAS | 135062-02-1 |
| Molecular Weight (g/mol) | 452.60 |
| ChEBI | CHEBI:8805 |
| MDL Number | MFCD00906179 |
| SMILES | CCOC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O |
| Synonym | (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic Acid |
| IUPAC Name | 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid |
| InChI Key | FAEKWTJYAYMJKF-QHCPKHFHSA-N |
| Molecular Formula | C27H36N2O4 |
Sertraline Hydrochloride 98.0+%, TCI America™
CAS: 79559-97-0 Molecular Formula: C17H18Cl3N Molecular Weight (g/mol): 342.688 MDL Number: MFCD00895772 InChI Key: BLFQGGGGFNSJKA-XHXSRVRCSA-N Synonym: (1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride PubChem CID: 63009 ChEBI: CHEBI:9124 IUPAC Name: (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride SMILES: CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl
| PubChem CID | 63009 |
|---|---|
| CAS | 79559-97-0 |
| Molecular Weight (g/mol) | 342.688 |
| ChEBI | CHEBI:9124 |
| MDL Number | MFCD00895772 |
| SMILES | CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl |
| Synonym | (1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride |
| IUPAC Name | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride |
| InChI Key | BLFQGGGGFNSJKA-XHXSRVRCSA-N |
| Molecular Formula | C17H18Cl3N |
Pioglitazone Hydrochloride 98.0+%, TCI America™
CAS: 112529-15-4 Molecular Formula: C19H21ClN2O3S Molecular Weight (g/mol): 392.898 MDL Number: MFCD04975446 InChI Key: GHUUBYQTCDQWRA-UHFFFAOYSA-N Synonym: 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride PubChem CID: 60560 IUPAC Name: 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride SMILES: CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl
| PubChem CID | 60560 |
|---|---|
| CAS | 112529-15-4 |
| Molecular Weight (g/mol) | 392.898 |
| MDL Number | MFCD04975446 |
| SMILES | CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl |
| Synonym | 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride |
| IUPAC Name | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;hydrochloride |
| InChI Key | GHUUBYQTCDQWRA-UHFFFAOYSA-N |
| Molecular Formula | C19H21ClN2O3S |
Protamine Sulfate from Salmon sperm, TCI America™
CAS: 53597-25-4 MDL Number: MFCD00132091 Synonym: Salmine Sulfate
| CAS | 53597-25-4 |
|---|---|
| MDL Number | MFCD00132091 |
| Synonym | Salmine Sulfate |
Abiraterone Acetate 98.0+%, TCI America™
CAS: 154229-18-2 Molecular Formula: C26H33NO2 Molecular Weight (g/mol): 391.555 MDL Number: MFCD00934213 InChI Key: UVIQSJCZCSLXRZ-UBUQANBQSA-N Synonym: 3beta-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate PubChem CID: 9821849 ChEBI: CHEBI:68639 IUPAC Name: [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate SMILES: CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C
| PubChem CID | 9821849 |
|---|---|
| CAS | 154229-18-2 |
| Molecular Weight (g/mol) | 391.555 |
| ChEBI | CHEBI:68639 |
| MDL Number | MFCD00934213 |
| SMILES | CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C |
| Synonym | 3beta-17-(3-Pyridyl)androsta-5,16-dien-3-ol Acetate |
| IUPAC Name | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
| InChI Key | UVIQSJCZCSLXRZ-UBUQANBQSA-N |
| Molecular Formula | C26H33NO2 |
Nitazoxanide 98.0+%, TCI America™
CAS: 55981-09-4 Molecular Formula: C12H9N3O5S Molecular Weight (g/mol): 307.28 MDL Number: MFCD00416599 InChI Key: YQNQNVDNTFHQSW-UHFFFAOYSA-N Synonym: 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, NTZ PubChem CID: 41684 IUPAC Name: [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate SMILES: CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]
| PubChem CID | 41684 |
|---|---|
| CAS | 55981-09-4 |
| Molecular Weight (g/mol) | 307.28 |
| MDL Number | MFCD00416599 |
| SMILES | CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] |
| Synonym | 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide, NTZ |
| IUPAC Name | [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate |
| InChI Key | YQNQNVDNTFHQSW-UHFFFAOYSA-N |
| Molecular Formula | C12H9N3O5S |
Medisca Oxybutynin Chloride USP
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Oxybutynin Chloride USP is a white crystalline powder, which is practically odorless . Alternative name(s): Oxybutynin hydrochloride
| CAS | 1508-65-2 |
|---|
Medisca Ibuprofen USP
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Ibuprofen USP is a white to off-white, crystalline powder, having a slight, characteristic odor.
| CAS | 15687-27-1 |
|---|
Medisca Pramoxine Hydrochloride USP
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Pramoxine Hydrochloride USP is a white to practically white, crystalline powder. May have a slight aromatic odor. Alternative name(s): Pramocaine Hydrochloride
| CAS | 637-58-1 |
|---|
Medisca Guaifenesin, USP
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Guaifenesin USP is a white to slightly gray, crystalline powder. May have a slight characteristic odor. Alternative name(s): GLycerol guaiacolate, guaiphenesin
| CAS | 93-14-1 |
|---|
Medisca Bupivacaine Hydrochloride USP (Monohydrate)
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bupivacaine Hydrochloride USP is a white, odorless, crystalline powder. Alternative name(s): bupivacaine hydrochloride monohydrate, Bupivacaine HCL
| CAS | 73360-54-0 |
|---|
Medisca Bismuth Subnitrate USP
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Bismuth Subnitrate USP is a white, slightly hygroscopic powder. Alternative name(s): Bismuth hydroxide nitrate oxide
| CAS | 1304-85-4 |
|---|
Medisca Polysorbate 80 NF (Tween 80)
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Polysorbate 80 NF is a lemon to amber-colored, oily liquid having a faint characteristic odor.
| CAS | 9005-65-6 |
|---|